Cystagon GE (Cysteamine Capsule) 50mg

Cystagon GE (Cysteamine) 50mg capsules provide cysteamine bitartrate for cystinosis management. Store below 25°C and keep tightly sealed. Suitable for patients requiring cysteamine therapy. Consult healthcare provider for personalized guidance.

Strength

50mg

Pack Size

100s

Storage

Below 25°C

Manufacturer / TM Owner

Recordati Pharma GmbH

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cystagon GE (cysteamine) 50mg capsules are used to treat nephropathic cystinosis, a rare genetic disorder causing cystine buildup in cells. This medication helps reduce cystine accumulation in the kidneys and other organs. It is prescribed to manage symptoms and slow disease progression in patients diagnosed with cystinosis.

Side Effects

Cystagon GE capsules work by binding to cystine inside cells, helping the body remove excess cystine. Patients may experience improved kidney function and reduced symptoms over time. Regular use as directed is important for maintaining therapeutic benefits. Individual responses to treatment may vary.

Precautions & Warnings

Keep Cystagon GE capsules tightly sealed and store below 25°C to maintain potency. Protect from moisture and direct sunlight. Handle with care to avoid contamination. Always follow the storage instructions provided with the medication. Consult your pharmacist if you have questions about proper storage.

Avoid Interactions

Cystagon GE may interact with other medications that affect stomach acid or kidney function. Avoid alcohol while taking this medication unless advised otherwise by a healthcare professional. Some drugs, such as those metabolized by certain liver enzymes, may alter cysteamine levels. Inform your doctor about all medications you are taking.

Frequently Asked Questions

Cystagon GE is used to treat nephropathic cystinosis by reducing cystine buildup in cells.

Store below 25°C in a tightly sealed container, away from moisture and direct sunlight.

Consult your healthcare provider before combining with other drugs to avoid potential interactions.

Take the missed dose as soon as you remember, but skip it if it’s almost time for the next dose.

Long-term use should be monitored by a healthcare professional to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.